![Matthew Killeen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Killeen
Directeur Technique/Scientifique/R&D chez
RENOVACOR, INC.
Profil
Matthew Killeen is currently the Director at Sudden Cardiac Arrest Foundation, Advisor-Scientific Affairs at CREAGRI, Inc., and Chief Scientific Officer at Renovacor, Inc. He previously worked as the Head-Cardiovascular Research at BioMarin Pharmaceutical, Inc. and as a Principal at Eli Lilly & Co. Ltd. Killeen holds a doctorate degree from the University of Cambridge and an undergraduate degree from the University of Leeds.
Postes actifs de Matthew Killeen
| Sociétés | Poste | Début |
|---|---|---|
| RENOVACOR, INC. | Directeur Technique/Scientifique/R&D | 01/09/2021 |
CREAGRI, Inc.
 CREAGRI, Inc. Food RetailRetail Trade Develops and supplies antioxidant polyphenols | Corporate Officer/Principal | 12/05/2011 |
Sudden Cardiac Arrest Foundation
 Sudden Cardiac Arrest Foundation Miscellaneous Commercial ServicesCommercial Services Sudden Cardiac Arrest Foundation is a nonprofit organization dedicated to raising awareness about sudden cardiac arrest and saving lives through education, research, and community support. The non-profit company is located in the US. It empowers the public to act quickly in emergencies by promoting CPR and automated external defibrillator training, emphasizing the "call-push-shock" sequence to improve survival rates. The foundation provides resources on sudden cardiac arrest, including risk factors, treatment options, and survivor support, and runs programs such as the cardiac arrest survival video contest, volunteer initiatives, and awareness events. It collaborates with academic institutions on research related to survivor experiences and quality of life, and offers guidance on heart screening, emergency response planning, and recovery challenges. The organization engages the community through survivor stories, training, advocacy for improved CPR/AED laws, and opportunities for volunteering and fundraising. | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Killeen
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Directeur Technique/Scientifique/R&D | - |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Corporate Officer/Principal | - |
Formation de Matthew Killeen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
CREAGRI, Inc.
CREAGRI, Inc. Food RetailRetail Trade Develops and supplies antioxidant polyphenols | Retail Trade |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
Sudden Cardiac Arrest Foundation
Sudden Cardiac Arrest Foundation Miscellaneous Commercial ServicesCommercial Services Sudden Cardiac Arrest Foundation is a nonprofit organization dedicated to raising awareness about sudden cardiac arrest and saving lives through education, research, and community support. The non-profit company is located in the US. It empowers the public to act quickly in emergencies by promoting CPR and automated external defibrillator training, emphasizing the "call-push-shock" sequence to improve survival rates. The foundation provides resources on sudden cardiac arrest, including risk factors, treatment options, and survivor support, and runs programs such as the cardiac arrest survival video contest, volunteer initiatives, and awareness events. It collaborates with academic institutions on research related to survivor experiences and quality of life, and offers guidance on heart screening, emergency response planning, and recovery challenges. The organization engages the community through survivor stories, training, advocacy for improved CPR/AED laws, and opportunities for volunteering and fundraising. | Commercial Services |
Choisissez Zonebourse 
